España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Chemed
CHE
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$550.97
9.32
1.72%
At close: -
$540.30
-10.67
-1.94%
After Hours: Jan 24, 8:20 AM EDT
Get Report
Comment
Chemed (CHE) Forecast
News
Earnings
Chemed (CHE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Chemed (NYSE:CHE) Stock
Chemed Stock (NYSE: CHE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 20, 2025
Here's How Much $1000 Invested In Chemed 20 Years Ago Would Be Worth Today
Benzinga Insights
Thursday, January 09, 2025
Here's How Much You Would Have Made Owning Chemed Stock In The Last 20 Years
Benzinga Insights
Friday, December 20, 2024
(CHE) - Analyzing Chemed's Short Interest
Benzinga Insights
Monday, December 16, 2024
$100 Invested In Chemed 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
Monday, November 25, 2024
How Is The Market Feeling About Chemed?
Benzinga Insights
Friday, November 08, 2024
Chemed Authorizes An Additional $300M For Sto...
Benzinga Newsdesk
Tuesday, November 05, 2024
RBC Capital Maintains Outperform on Chemed, L...
Benzinga Newsdesk
Wednesday, October 30, 2024
Chemed shares are trading lower after the com...
Benzinga Newsdesk
Tuesday, October 29, 2024
Chemed Sees FY24 EPS $23.00-$23.15 Vs $23.58 ...
Benzinga Newsdesk
Chemed Q3 2024 Adj. EPS $5.64 Misses $5.76 Es...
Benzinga Newsdesk
Monday, October 28, 2024
Peering Into Chemed's Recent Short Interest
Benzinga Insights
Friday, October 25, 2024
$1000 Invested In This Stock 15 Years Ago Would Be Worth $13,000 Today
Benzinga Insights
Thursday, October 24, 2024
Breaking Update: Nicholas M. Westfall Engages In Options Exercise At Chemed
Benzinga Insights
Michael D Witzeman Decides To Exercise Options At Chemed
Benzinga Insights
Brian C Judkins At Chemed Exercises Options
Benzinga Insights
Monday, October 21, 2024
Here's How Much You Would Have Made Owning Chemed Stock In The Last 20 Years
Benzinga Insights
Wednesday, October 02, 2024
Exxon Mobil, Chemed, Las Vegas Sands And More On CNBC's 'Final Trades'
Avi Kapoor
Tuesday, October 01, 2024
CNBC Halftime Report Final Trades: Exxon Mobi...
Benzinga Newsdesk
Monday, September 30, 2024
AMED Or CHE: Which Is The Better Value Stock Right Now?
Zacks
Friday, September 06, 2024
Major Exercise Alert: Nicholas M. Westfall Exercises Options Worth $1.56M At Chemed
Benzinga Insights
Wednesday, August 28, 2024
Looking Into Chemed's Recent Short Interest
Benzinga Insights
Friday, August 02, 2024
Chemed Executive Vice President Trades Company's Stock
Benzinga Insights
Insider Activity Update: Michael D Witzeman Executes Options Exercise, Resulting In $927K At Chemed
Benzinga Insights
Thursday, August 01, 2024
Insider Decision: Nicholas M. Westfall Offloads $1.12M Worth Of Chemed Stock
Benzinga Insights
Wednesday, July 31, 2024
Chemed Recent Insider Activity
Benzinga Insights
Wednesday, July 24, 2024
Chemed Raises FY24 EPS From $23.30-$23.70 To ...
Benzinga Newsdesk
Chemed Q2 Adj $5.47 Misses $5.59 Estimate, Sa...
Benzinga Newsdesk
Tuesday, July 16, 2024
How Is The Market Feeling About Chemed?
Benzinga Insights
Should You Keep Chemed Stock in Your Portfolio Now?
Zacks
Monday, July 15, 2024
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
Benzinga Insights
Thursday, June 13, 2024
(CHE) - Analyzing Chemed's Short Interest
Benzinga Insights
Tuesday, May 21, 2024
RBC Capital Maintains Outperform on Chemed, L...
Benzinga Newsdesk
Thursday, May 02, 2024
Peering Into Chemed's Recent Short Interest
Benzinga Insights
Thursday, April 25, 2024
Chemed shares are trading lower after the com...
Benzinga Newsdesk
Wednesday, April 24, 2024
Chemed Sees FY24 EPS $23.30-$23.70 Vs $23.52 ...
Benzinga Newsdesk
Chemed Q1 Adj $5.20 Misses $5.48 Estimate, Sa...
Benzinga Newsdesk
Wednesday, March 13, 2024
VITAS, A Wholly-Owned Subsidiary Of Chemed To...
Benzinga Newsdesk
Monday, March 04, 2024
(CHE) - Analyzing Chemed's Short Interest
Benzinga Insights
RBC Capital Maintains Outperform on Chemed, R...
Benzinga Newsdesk
Thursday, February 29, 2024
Oppenheimer Maintains Outperform on Chemed, R...
Benzinga Newsdesk
Tuesday, February 27, 2024
Chemed Q4 2023 Adj EPS $6.60 Beats $6.25 Esti...
Benzinga Newsdesk
Chemed: Q4 Earnings Insights
Benzinga Insights
Earnings Scheduled For February 27, 2024
Benzinga Insights
Tuesday, February 20, 2024
Chemed: Dividend Insights
Benzinga Insights
Wednesday, January 17, 2024
Oppenheimer Maintains Outperform on Chemed, R...
Benzinga Newsdesk
Monday, December 18, 2023
Chemed Corporation Announces The Appointment ...
Benzinga Newsdesk
Wednesday, November 08, 2023
Chemed Form4 Filing Shows CFO Patrick David W...
Benzinga Newsdesk
Tuesday, November 07, 2023
Chemed: Dividend Insights
Benzinga Insights
Monday, November 06, 2023
Chemed Corporation's Board Of Directors Autho...
Benzinga Newsdesk
Friday, November 03, 2023
Chemed Corporation Announces The Retirement O...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
